Literature DB >> 30937713

Lymph Node Noncompliance Affects the Long-Term Prognosis of Patients with Gastric Cancer after Laparoscopic Total Gastrectomy.

Guang-Tan Lin1,2, Qi-Yue Chen1,2,3, Chao-Hui Zheng1,2,3, Ping Li1,2,3, Jian-Wei Xie1,2,3, Jia-Bin Wang1,2,3, Jian-Xian Lin1,2,3, Jun Lu1,2,3, Long-Long Cao1,2, Mi Lin1,2, Ru-Hong Tu1,2, Ze-Ning Huang1,2, Ju-Li Lin1,2, Chang-Ming Huang4,5,6.   

Abstract

BACKGROUND: Our study investigated the effect of lymph node (LN) noncompliance on the long-term prognosis of patients after laparoscopic total gastrectomy (LTG) and explored the risk factors of LN noncompliance.
METHODS: The clinicopathological data of gastric cancer (GC) patients who underwent LTG with D2 lymphadenectomy from June 2007 to December 2013 were prospectively collected and retrospectively analyzed. The effects of LN noncompliance on the long-term prognosis of patients with GC after LTG were explored.
RESULTS: The overall LN noncompliance rate was 51.9%. The survival rate of patients after LTG with LN compliance was significantly superior to that of patients with LN noncompliance (p = 0.013). The stratified analysis of TNM stage indicated that there was no difference between the OS of stage I patients with LN compliance and those with LN noncompliance; OS of stage II/III patients with LN compliance was significantly better than that of those with LN noncompliance. Cox regression analyses showed that LN noncompliance was an independent risk factor for OS. Logistic regression analysis showed that high BMI (≥ 25 kg/m2) was an independent risk factor for preoperative prediction of LN noncompliance in cStage II/III patients. Patients with a high BMI were more likely to have LN noncompliance during surgery, especially during the dissections of #6, #8a, and #12a LN stations.
CONCLUSIONS: LN noncompliance was an independent risk factor for poor prognosis in patients with advanced gastric cancer (AGC) after LTG. Patients with high BMI were more likely to have LN noncompliance, especially during the dissections of #6, #8a, and #12a LN stations. LN tracing was recommended for these patients to reduce the rate of LN noncompliance.

Entities:  

Keywords:  D2 lymphadenectomy; LN noncompliance; gastric carcinoma; laparoscopic total gastrectomy; prognosis

Mesh:

Year:  2019        PMID: 30937713     DOI: 10.1007/s11605-019-04199-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  38 in total

1.  Quality control of lymph node dissection in the Dutch Gastric Cancer Trial.

Authors:  W O de Steur; H H Hartgrink; J L Dikken; H Putter; C J H van de Velde
Journal:  Br J Surg       Date:  2015-08-27       Impact factor: 6.939

2.  A totally laparoscopic distal gastrectomy can be an effective way of performing laparoscopic gastrectomy in obese patients (body mass index≥30).

Authors:  Min Gyu Kim; Kap Choong Kim; Beom Su Kim; Tae Hwan Kim; Hee Sung Kim; Jeong Hwan Yook; Byung Sik Kim
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

3.  Short-term outcome of total laparoscopic distal gastrectomy for overweight and obese patients with gastric cancer.

Authors:  Motokazu Sugimoto; Takahiro Kinoshita; Hidehito Shibasaki; Yuichiro Kato; Naoto Gotohda; Shinichiro Takahashi; Masaru Konishi
Journal:  Surg Endosc       Date:  2013-06-21       Impact factor: 4.584

4.  Surgicopathological Quality Control and Protocol Adherence to Lymphadenectomy in the CRITICS Gastric Cancer Trial.

Authors:  Yvette H M Claassen; Wobbe O de Steur; Henk H Hartgrink; Johan L Dikken; Johanna W van Sandick; Nicole C T van Grieken; Annemiek Cats; Anouk K Trip; Edwin P M Jansen; Willemina M Meershoek-Klein Kranenbarg; Jeffrey P B M Braak; Hein Putter; Mark I van Berge Henegouwen; Marcel Verheij; Cornelis J H van de Velde
Journal:  Ann Surg       Date:  2018-12       Impact factor: 12.969

5.  An approach for the treatment of penile carcinoma.

Authors:  R M Cabanas
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860

6.  The general rules for the gastric cancer study in surgery ad pathology. Part II. Histological classification of gastric cancer.

Authors: 
Journal:  Jpn J Surg       Date:  1981-03

7.  Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.

Authors:  Se Hoon Park; Tae Sung Sohn; Jeeyun Lee; Do Hoon Lim; Min Eui Hong; Kyoung-Mee Kim; Insuk Sohn; Sin Ho Jung; Min Gew Choi; Jun Ho Lee; Jae Moon Bae; Sung Kim; Seung Tae Kim; Joon Oh Park; Young Suk Park; Ho Yeong Lim; Won Ki Kang
Journal:  J Clin Oncol       Date:  2015-01-05       Impact factor: 44.544

8.  A prospective randomized study comparing open vs laparoscopy-assisted distal gastrectomy in early gastric cancer: early results.

Authors:  J-H Lee; H-S Han; J-H Lee
Journal:  Surg Endosc       Date:  2004-12-09       Impact factor: 4.584

9.  Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.

Authors:  H H Hartgrink; C J H van de Velde; H Putter; J J Bonenkamp; E Klein Kranenbarg; I Songun; K Welvaart; J H J M van Krieken; S Meijer; J T M Plukker; P J van Elk; H Obertop; D J Gouma; J J B van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus; M Sasako
Journal:  J Clin Oncol       Date:  2004-04-13       Impact factor: 44.544

10.  Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

Authors:  A Cuschieri; S Weeden; J Fielding; J Bancewicz; J Craven; V Joypaul; M Sydes; P Fayers
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  6 in total

1.  Laparoscopic total gastrectomy for upper-middle advanced gastric cancer: analysis based on lymph node noncompliance.

Authors:  Qi-Yue Chen; Guang-Tan Lin; Qing Zhong; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Jun Lu; Long-Long Cao; Chang-Ming Huang
Journal:  Gastric Cancer       Date:  2019-07-12       Impact factor: 7.370

Review 2.  [ICG lymph node mapping in cancer surgery of the upper gastrointestinal tract].

Authors:  Dolores Müller; Raphael Stier; Jennifer Straatman; Benjamin Babic; Lars Schiffmann; Jennifer Eckhoff; Thomas Schmidt; Christiane Bruns; Hans F Fuchs
Journal:  Chirurgie (Heidelb)       Date:  2022-06-03

3.  Pattern of No. 12a lymph node metastasis in gastric cancer.

Authors:  Ping Shu; Xiangfei Sun; Fenglin Liu; Yong Fang; Kuntang Shen; Yihong Sun; Jing Qin; Xinyu Qin
Journal:  Chin J Cancer Res       Date:  2021-02-28       Impact factor: 5.087

4.  Exploring the scope of 4sb and 12a lymph node dissection for cT2-4 lower third gastric cancer: Study protocol for a prospective cohort trial.

Authors:  Haiqiao Zhang; Zhi Zheng; Xiaoye Liu; Jun Cai; Jie Yin; Jun Zhang
Journal:  Front Surg       Date:  2022-07-14

5.  Determination of the extent of dissection in early gastric cancer based on lymph node station power index.

Authors:  Chul-Hyo Jeon; Ki Bum Park; Sojung Kim; Ho Seok Seo; In-Ho Kim; Kyo Young Song; Han Hong Lee
Journal:  BJS Open       Date:  2022-09-02

6.  Value of the preoperative prognostic nutritional index for the evaluation of patient prognosis after radical gastrectomy.

Authors:  Lili Wang; Yongzhi Miao; Tianwen Chen; Dengzhong Sun; Sitang Ge; Lugen Zuo; Mulin Liu
Journal:  Mol Clin Oncol       Date:  2020-01-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.